[Antiemetic effect of domperidone (R 33 812) in children undergoing cytotoxic therapy].
D000293:Adolescent; D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001562:Benzimidazoles / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009325:Nausea / Q000188:drug therapy* / Q000209:etiology; D010880:Piperidines / Q000627:therapeutic use*; D014839:Vomiting / Q000188:drug therapy* / Q000209:etiology
D000932:Antiemetics; D000970:Antineoplastic Agents; D001562:Benzimidazoles; D010880:Piperidines
L'effet antiémétique de la dompéridone (R 33 812) chez les enfants soumis à une cure cytotoxique.